$HRZN
Horizon Technology Finance Corp

2023 Q2 Form 10-Q Financial Statement

#000143774923012114 Filed on May 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $12.20M $13.20M $12.00M
YoY Change -30.79% 9.99% -9.32%
Cost Of Revenue $11.32M $14.40M $8.031M
YoY Change 18.67% 79.27% 18.28%
Gross Profit $877.0K $5.935M $3.966M
YoY Change -89.15% 49.65% -38.51%
Gross Profit Margin 7.19% 44.98% 33.06%
Selling, General & Admin $546.0K $445.0K $344.0K
YoY Change 50.83% 29.36% -7.03%
% of Gross Profit 62.26% 7.5% 8.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $546.0K $445.0K $344.0K
YoY Change 50.83% 29.36% -4.44%
Operating Profit $331.0K $5.490M $3.622M
YoY Change -95.71% 51.57% -40.53%
Interest Expense $7.179M $7.120M $3.424M
YoY Change 69.92% 107.94%
% of Operating Profit 2168.88% 129.69% 94.53%
Other Income/Expense, Net
YoY Change
Pretax Income $331.0K $5.490M $3.622M
YoY Change -95.71% 51.57% -40.43%
Income Tax $179.0K $184.0K $100.0K
% Of Pretax Income 54.08% 3.35% 2.76%
Net Earnings $152.0K $5.306M $3.522M
YoY Change -98.0% 50.65% -41.5%
Net Earnings / Revenue 1.25% 40.21% 29.36%
Basic Earnings Per Share $0.54 $0.46 $0.26
Diluted Earnings Per Share $0.01 $0.19 $160.8K
COMMON SHARES
Basic Shares Outstanding 28.66M 28.32M 21.90M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.26M $43.54M $14.46M
YoY Change -34.14% 201.06% -82.06%
Cash & Equivalents $25.87M $46.53M $2.011M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $65.15M $57.39M $22.77M
YoY Change -23.7% 152.04% -73.65%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $715.4M $715.3M $516.5M
YoY Change 23.54% 38.49% 35.36%
Other Assets $2.904M $2.987M $1.500M
YoY Change 99.13%
Total Long-Term Assets $722.3M $720.9M $518.8M
YoY Change 23.99% 38.95% 35.38%
TOTAL ASSETS
Total Short-Term Assets $65.15M $57.39M $22.77M
Total Long-Term Assets $722.3M $720.9M $518.8M
Total Assets $787.4M $778.2M $541.5M
YoY Change 17.89% 43.71% 15.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $2.200M $3.508M $1.652M
YoY Change 9.07% 112.35% -13.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $42.93M $0.00
YoY Change 350.18% -100.0%
Total Short-Term Liabilities $56.91M $16.91M $11.05M
YoY Change 158.35% 52.98% -80.4%
LONG-TERM LIABILITIES
Long-Term Debt $375.1M $439.6M $250.5M
YoY Change 5.57% 75.51% 28.07%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $375.1M $439.6M $250.5M
YoY Change 5.57% 75.51% 28.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.91M $16.91M $11.05M
Total Long-Term Liabilities $375.1M $439.6M $250.5M
Total Liabilities $432.0M $456.6M $261.6M
YoY Change 14.49% 74.55% 3.83%
SHAREHOLDERS EQUITY
Retained Earnings -$82.18M -$71.66M
YoY Change
Common Stock $34.00K $30.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $355.4M $321.7M $280.0M
YoY Change
Total Liabilities & Shareholders Equity $787.4M $778.2M $541.5M
YoY Change 17.89% 43.71% 15.32%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $152.0K $5.306M $3.522M
YoY Change -98.0% 50.65% -41.5%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$5.484M $12.73M -$55.36M
YoY Change -90.1% -122.99% 164.51%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $9.039M $6.227M
YoY Change 45.16%
Common Stock Issuance & Retirement, Net $38.19M
YoY Change 682.52%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.12M $3.333M 24.06M
YoY Change -89.67% -86.15% -56.48%
NET CHANGE
Cash From Operating Activities -5.484M $12.73M -55.36M
Cash From Investing Activities
Cash From Financing Activities 12.12M $3.333M 24.06M
Net Change In Cash 6.635M $16.06M -31.30M
YoY Change -89.28% -151.31% -191.13%
FREE CASH FLOW
Cash From Operating Activities -$5.484M $12.73M -$55.36M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
724162000 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
721248000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28544822
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27920838
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28377357
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27753373
CY2023Q1 hrzn Investment Owned Nav Percent
InvestmentOwnedNavPercent
2.224 pure
CY2022Q4 hrzn Investment Owned Nav Percent
InvestmentOwnedNavPercent
2.261 pure
CY2023Q1 hrzn Investments Nonaccrual Interest Income
InvestmentsNonaccrualInterestIncome
0 usd
CY2022Q1 hrzn Investments Nonaccrual Interest Income
InvestmentsNonaccrualInterestIncome
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q1 us-gaap Open Tax Year
OpenTaxYear
2019 2020 2021
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2022Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
814-00802
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q4 us-gaap Cash
Cash
20612000 usd
CY2023Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
23698000 usd
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
7066000 usd
CY2023Q1 us-gaap Restricted Investments
RestrictedInvestments
2987000 usd
CY2022Q4 us-gaap Restricted Investments
RestrictedInvestments
2788000 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
13843000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
13573000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
2554000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
2761000 usd
CY2023Q1 us-gaap Assets
Assets
778238000 usd
CY2022Q4 us-gaap Assets
Assets
766826000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
439645000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
434078000 usd
CY2023Q1 us-gaap Distribution Payable
DistributionPayable
9365000 usd
CY2022Q4 us-gaap Distribution Payable
DistributionPayable
9159000 usd
CY2023Q1 us-gaap Management Fee Payable
ManagementFeePayable
1059000 usd
CY2022Q4 us-gaap Management Fee Payable
ManagementFeePayable
1065000 usd
CY2023Q1 us-gaap Incentive Fee Payable
IncentiveFeePayable
2978000 usd
CY2022Q4 us-gaap Incentive Fee Payable
IncentiveFeePayable
1392000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
3508000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
2684000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
456555000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
448378000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
30000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
29000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
393312000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
385921000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71659000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67502000 usd
CY2023Q1 hrzn Net Assets
NetAssets
321683000 usd
CY2022Q4 hrzn Net Assets
NetAssets
318448000 usd
CY2023Q1 hrzn Liabilities And Net Assets
LiabilitiesAndNetAssets
778238000 usd
CY2022Q4 hrzn Liabilities And Net Assets
LiabilitiesAndNetAssets
766826000 usd
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2114934
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
312 Farmington Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Farmington
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06032
CY2023Q1 dei City Area Code
CityAreaCode
860
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
676‑8654
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.34
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.47
CY2023Q1 hrzn Investment Company Investment Income Net
InvestmentCompanyInvestmentIncomeNet
28037000 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28656554
CY2023Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
715312000 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
720026000 usd
CY2023Q1 us-gaap Cash
Cash
19844000 usd
CY2022Q1 hrzn Investment Company Investment Income Net
InvestmentCompanyInvestmentIncomeNet
14204000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
7120000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
3424000 usd
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
3201000 usd
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
2244000 usd
CY2023Q1 hrzn Performance Based Incentive Fee
PerformanceBasedIncentiveFee
2978000 usd
CY2022Q1 hrzn Performance Based Incentive Fee
PerformanceBasedIncentiveFee
1424000 usd
CY2023Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
440000 usd
CY2022Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
362000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
658000 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
577000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
445000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
344000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
14842000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
8375000 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
13195000 usd
CY2022Q1 us-gaap Net Investment Income
NetInvestmentIncome
5829000 usd
CY2023Q1 us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
184000 usd
CY2022Q1 us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
100000 usd
CY2023Q1 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
13011000 usd
CY2022Q1 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
5729000 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-168000 usd
CY2022Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
30000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-7537000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2237000 usd
CY2023Q1 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-7705000 usd
CY2022Q1 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-2207000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5306000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3522000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2023Q1 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
0.19
CY2022Q1 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
0.16
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28227100
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21904160
CY2021Q4 us-gaap Assets Net
AssetsNet
245335000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38187000 usd
CY2022Q1 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
5729000 usd
CY2022Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
30000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2237000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
145000 usd
CY2022Q1 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
7200000 usd
CY2022Q1 us-gaap Assets Net
AssetsNet
279989000 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
318448000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7174000 usd
CY2023Q1 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
13011000 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-168000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-7537000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
218000 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
721248000 usd
CY2023Q1 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
9463000 usd
CY2023Q1 us-gaap Assets Net
AssetsNet
321683000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5306000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3522000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
478000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
336000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-168000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
30000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-7537000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2237000 usd
CY2023Q1 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
47008000 usd
CY2022Q1 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
94485000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Securities Operating Activities
ProceedsFromMaturitiesPrepaymentsAndCallsOfSecuritiesOperatingActivities
39756000 usd
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Securities Operating Activities
ProceedsFromMaturitiesPrepaymentsAndCallsOfSecuritiesOperatingActivities
14145000 usd
CY2023Q1 us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
1204000 usd
CY2022Q1 us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
-0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
6520000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
21280000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-840000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
866000 usd
CY2023Q1 hrzn Increase Decrease In Endofterm Payments
IncreaseDecreaseInEndoftermPayments
1017000 usd
CY2022Q1 hrzn Increase Decrease In Endofterm Payments
IncreaseDecreaseInEndoftermPayments
1285000 usd
CY2023Q1 hrzn Increase Decrease In Unearned Income
IncreaseDecreaseInUnearnedIncome
1148000 usd
CY2022Q1 hrzn Increase Decrease In Unearned Income
IncreaseDecreaseInUnearnedIncome
81000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-98000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-652000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
824000 usd
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-274000 usd
CY2023Q1 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
-6000 usd
CY2022Q1 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
79000 usd
CY2023Q1 us-gaap Increase Decrease In Incentive Fee Payable
IncreaseDecreaseInIncentiveFeePayable
1586000 usd
CY2022Q1 us-gaap Increase Decrease In Incentive Fee Payable
IncreaseDecreaseInIncentiveFeePayable
-591000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12730000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55361000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7174000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38187000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10000000 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
25000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
-0 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20000000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
19000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
550000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
9039000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
6227000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3333000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24058000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16063000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31303000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30466000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47281000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46529000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15978000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
6623000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
3044000 usd
CY2023Q1 hrzn Warrant Investments Received And Recorded As Unearned Income
WarrantInvestmentsReceivedAndRecordedAsUnearnedIncome
141000 usd
CY2022Q1 hrzn Warrant Investments Received And Recorded As Unearned Income
WarrantInvestmentsReceivedAndRecordedAsUnearnedIncome
1174000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
9365000 usd
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
7193000 usd
CY2023Q1 hrzn Endofterm Payments Receivable Noncash Transaction
EndoftermPaymentsReceivableNoncashTransaction
10799000 usd
CY2022Q1 hrzn Endofterm Payments Receivable Noncash Transaction
EndoftermPaymentsReceivableNoncashTransaction
6522000 usd
CY2023Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
3944000 usd
CY2022Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
1424000 usd
CY2023Q1 us-gaap Cash
Cash
19844000 usd
CY2022Q1 us-gaap Cash
Cash
12452000 usd
CY2023Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
23698000 usd
CY2022Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
2011000 usd
CY2023Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
2987000 usd
CY2022Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
1515000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46529000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15978000 usd
CY2023Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
724162000 usd
CY2023Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
715312000 usd
CY2023Q1 hrzn Percentage Of Nonqualifying Assets On A Cost Basis
PercentageOfNonqualifyingAssetsOnACostBasis
0.063 pure
CY2023Q1 hrzn Percentage Of Nonqualifying Assets On A Fair Value Basis
PercentageOfNonqualifyingAssetsOnAFairValueBasis
0.062 pure
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
721248000 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
720026000 usd
CY2022Q4 hrzn Percentage Of Nonqualifying Assets On A Cost Basis
PercentageOfNonqualifyingAssetsOnACostBasis
0.065 pure
CY2022Q4 hrzn Percentage Of Nonqualifying Assets On A Fair Value Basis
PercentageOfNonqualifyingAssetsOnAFairValueBasis
0.066 pure
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 11pt;"><b><i>Use of estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1 hrzn Investment Nonaccrual Income Not Received In Cash Percent
InvestmentNonaccrualIncomeNotReceivedInCashPercent
0.063 pure
CY2022Q1 hrzn Investment Nonaccrual Income Not Received In Cash Percent
InvestmentNonaccrualIncomeNotReceivedInCashPercent
0.095 pure
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6600000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7100000 usd
CY2023Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
5300000 usd
CY2022Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
4800000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
500000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
300000 usd
CY2023Q1 hrzn Federal Excise Tax Percent
FederalExciseTaxPercent
0.04 pure
CY2023Q1 us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
200000 usd
CY2022Q1 us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
100000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
32659000 usd
CY2022 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
61859
CY2022Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
5000000.0 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
167465
hrzn Stock Repurchased During Period Per Share
StockRepurchasedDuringPeriodPerShare
11.22
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1900000 usd
CY2023Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
724162000 usd
CY2023Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
715312000 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
721248000 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
720026000 usd
CY2023Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
724162000 usd
CY2023Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
715312000 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
720026000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
716319000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
47008000 usd
CY2023Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived
141000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
39756000 usd
CY2023Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest
1204000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
6520000 usd
CY2023Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings
-134000 usd
CY2023Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings
-5867000 usd
CY2023Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments
0 usd
CY2023Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease
1012000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
713407000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
457557000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
94485000 usd
CY2022Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived
808000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
-14145000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-21280000 usd
CY2022Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings
30000 usd
CY2022Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings
-2120000 usd
CY2022Q1 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease
-1093000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
514242000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2022 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
754000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.33
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2023Q1 us-gaap Earnings Per Share Basic Undistributed
EarningsPerShareBasicUndistributed
0.81
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.47
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.56
CY2023Q1 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.46
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
577791000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
444541000 usd
CY2023Q1 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
133250000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
582573000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
439323000 usd
CY2022Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
143250000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4896000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5245000 usd
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
577791000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
439645000 usd
CY2023Q1 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
133250000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
582573000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
434078000 usd
CY2022Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
143250000 usd
CY2023Q1 hrzn Asset Coverage To Borrowings Ratio Percent
AssetCoverageToBorrowingsRatioPercent
1.72 pure
CY2023Q1 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
166200000 usd
CY2023Q1 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
1496000 usd
CY2022Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
190000000 usd
CY2022Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
1761000 usd
CY2023Q1 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
1500000 usd
CY2022Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
1800000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3035000 usd
CY2023Q1 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
6894
CY2023Q1 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
81000 usd
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.28
CY2022Q1 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.26
CY2023Q1 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.01
CY2022Q1 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0
CY2023Q1 hrzn Investment Company Investment Depreciation Appreciation Per Share
InvestmentCompanyInvestmentDepreciationAppreciationPerShare
-0.26
CY2022Q1 hrzn Investment Company Investment Depreciation Appreciation Per Share
InvestmentCompanyInvestmentDepreciationAppreciationPerShare
-0.10
CY2023Q1 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
0.19
CY2022Q1 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
0.16
CY2023Q1 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.33
CY2022Q1 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.30
CY2023Q1 hrzn Investment Company Distribution To Shareholders Per Share Net Investment Income
InvestmentCompanyDistributionToShareholdersPerShareNetInvestmentIncome
-0.33
CY2022Q1 hrzn Investment Company Distribution To Shareholders Per Share Net Investment Income
InvestmentCompanyDistributionToShareholdersPerShareNetInvestmentIncome
-0.30
CY2023Q1 hrzn Investment Company Distribution To Shareholders Per Share Net Realized Gain On Investments
InvestmentCompanyDistributionToShareholdersPerShareNetRealizedGainOnInvestments
0
CY2022Q1 hrzn Investment Company Distribution To Shareholders Per Share Net Realized Gain On Investments
InvestmentCompanyDistributionToShareholdersPerShareNetRealizedGainOnInvestments
0
CY2023Q1 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
0
CY2022Q1 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
0
CY2023Q1 hrzn Investment Company Distribution To Shareholders Per Share Other
InvestmentCompanyDistributionToShareholdersPerShareOther
0.01
CY2022Q1 hrzn Investment Company Distribution To Shareholders Per Share Other
InvestmentCompanyDistributionToShareholdersPerShareOther
0.26
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.34
CY2022Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.68
CY2022Q4 us-gaap Share Price
SharePrice
11.60
CY2021Q4 us-gaap Share Price
SharePrice
15.92
CY2023Q1 us-gaap Share Price
SharePrice
11.28
CY2022Q1 us-gaap Share Price
SharePrice
13.90
CY2023Q1 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.001 pure
CY2022Q1 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.108 pure
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28377357
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23977137
CY2023Q1 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.148 pure
CY2022Q1 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.106 pure
CY2023Q1 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.037 pure
CY2022Q1 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.022 pure
CY2023Q1 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.185 pure
CY2022Q1 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.128 pure
CY2023Q1 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.163 pure
CY2022Q1 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.087 pure
CY2023Q1 hrzn Net Assets
NetAssets
321683000 usd
CY2022Q1 hrzn Net Assets
NetAssets
279989000 usd
CY2023Q1 hrzn Average Net Assets
AverageNetAssets
320066000 usd
CY2022Q1 hrzn Average Net Assets
AverageNetAssets
262662000 usd
CY2023Q1 hrzn Investment Company Average Debt Per Share
InvestmentCompanyAverageDebtPerShare
15.61
CY2022Q1 hrzn Investment Company Average Debt Per Share
InvestmentCompanyAverageDebtPerShare
12.21
CY2023Q1 hrzn Investment Company Portfolio Turnover Ratio
InvestmentCompanyPortfolioTurnoverRatio
0.042 pure
CY2022Q1 hrzn Investment Company Portfolio Turnover Ratio
InvestmentCompanyPortfolioTurnoverRatio
0.026 pure

Files In Submission

Name View Source Status
hrzn-20230331_pre.xml Edgar Link unprocessable
hrzn-20230331_lab.xml Edgar Link unprocessable
0001437749-23-012114-index-headers.html Edgar Link pending
0001437749-23-012114-index.html Edgar Link pending
0001437749-23-012114.txt Edgar Link pending
0001437749-23-012114-xbrl.zip Edgar Link pending
ex_488265.htm Edgar Link pending
ex_488266.htm Edgar Link pending
ex_488267.htm Edgar Link pending
ex_488268.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hrzn-20230331.xsd Edgar Link pending
hrzn20230331b_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
hrzn-20230331_cal.xml Edgar Link unprocessable
hrzn-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
hrzn20230331b_10q_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending